tetano
Editor, Senior Moderator
Arch Gynecol Obstet
. 2022 Mar 9.
doi: 10.1007/s00404-022-06479-3. Online ahead of print.
Perinatal outcomes of pregnant women with severe COVID-19 requiring extracorporeal membrane oxygenation (ECMO): a case series and literature review
Sara Clemenza[SUP] 1 [/SUP], Sara Zullino[SUP] 2 [/SUP], Chiara Vacca[SUP] 2 [/SUP], Serena Simeone[SUP] 2 [/SUP], Caterina Serena[SUP] 2 [/SUP], Marianna Pina Rambaldi[SUP] 2 [/SUP], Serena Ottanelli[SUP] 2 [/SUP], Silvia Vannuccini[SUP] 2 [/SUP], Manuela Bonizzoli[SUP] 3 [/SUP], Adriano Peris[SUP] 3 [/SUP], Massimo Micaglio[SUP] 4 [/SUP], Felice Petraglia[SUP] 2 [/SUP], Federico Mecacci[SUP] 2 [/SUP]
Affiliations
Abstract
Purpose: Pregnant women with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have a higher risk of hospitalization, admission to intensive care unit (ICU) and invasive ventilation, and of acute respiratory distress syndrome (ARDS). In case of ARDS and critical severe coronavirus disease 2019 (COVID-19), the use of extracorporeal membrane oxygenation (ECMO) is recommended when other respiratory support strategies (oxygen insufflation, non-invasive ventilation [NIV], invasive ventilation through an endotracheal tube) are insufficient. However, available data on ECMO in pregnant and postpartum women with critical COVID-19 are very limited.
Methods: A case series of three critically ill pregnant women who required ECMO support for COVID-19 in pregnancy and/or in the postpartum period.
Results: The first patient tested positive for COVID-19 during the second trimester, she developed ARDS and required ECMO for 38 days. She was discharged in good general conditions and a cesarean-section [CS] at term was performed for obstetric indication. The second patient developed COVID-19-related ARDS at 28 weeks of gestation. During ECMO, she experienced a precipitous vaginal delivery at 31 weeks and 6 days of gestation. She was discharged 1 month later in good general conditions. The third patient, an obese 43-year-old woman, tested positive at 38 weeks and 2 days of gestation. Because of the worsening of clinical condition, a CS was performed, and she underwent ECMO. 143 days after the CS, she died because of sepsis and multiple organ failure (MOF). Thrombosis, hemorrhage and infections were the main complications among our patients. Neonatal outcomes have been positive.
Conclusion: ECMO should be considered a life-saving therapy for pregnant women with severe COVID-19.
Keywords: ARDS; COVID-19; ECMO; Pregnancy; SARS-CoV-2.
. 2022 Mar 9.
doi: 10.1007/s00404-022-06479-3. Online ahead of print.
Perinatal outcomes of pregnant women with severe COVID-19 requiring extracorporeal membrane oxygenation (ECMO): a case series and literature review
Sara Clemenza[SUP] 1 [/SUP], Sara Zullino[SUP] 2 [/SUP], Chiara Vacca[SUP] 2 [/SUP], Serena Simeone[SUP] 2 [/SUP], Caterina Serena[SUP] 2 [/SUP], Marianna Pina Rambaldi[SUP] 2 [/SUP], Serena Ottanelli[SUP] 2 [/SUP], Silvia Vannuccini[SUP] 2 [/SUP], Manuela Bonizzoli[SUP] 3 [/SUP], Adriano Peris[SUP] 3 [/SUP], Massimo Micaglio[SUP] 4 [/SUP], Felice Petraglia[SUP] 2 [/SUP], Federico Mecacci[SUP] 2 [/SUP]
Affiliations
- PMID: 35262778
- DOI: 10.1007/s00404-022-06479-3
Abstract
Purpose: Pregnant women with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have a higher risk of hospitalization, admission to intensive care unit (ICU) and invasive ventilation, and of acute respiratory distress syndrome (ARDS). In case of ARDS and critical severe coronavirus disease 2019 (COVID-19), the use of extracorporeal membrane oxygenation (ECMO) is recommended when other respiratory support strategies (oxygen insufflation, non-invasive ventilation [NIV], invasive ventilation through an endotracheal tube) are insufficient. However, available data on ECMO in pregnant and postpartum women with critical COVID-19 are very limited.
Methods: A case series of three critically ill pregnant women who required ECMO support for COVID-19 in pregnancy and/or in the postpartum period.
Results: The first patient tested positive for COVID-19 during the second trimester, she developed ARDS and required ECMO for 38 days. She was discharged in good general conditions and a cesarean-section [CS] at term was performed for obstetric indication. The second patient developed COVID-19-related ARDS at 28 weeks of gestation. During ECMO, she experienced a precipitous vaginal delivery at 31 weeks and 6 days of gestation. She was discharged 1 month later in good general conditions. The third patient, an obese 43-year-old woman, tested positive at 38 weeks and 2 days of gestation. Because of the worsening of clinical condition, a CS was performed, and she underwent ECMO. 143 days after the CS, she died because of sepsis and multiple organ failure (MOF). Thrombosis, hemorrhage and infections were the main complications among our patients. Neonatal outcomes have been positive.
Conclusion: ECMO should be considered a life-saving therapy for pregnant women with severe COVID-19.
Keywords: ARDS; COVID-19; ECMO; Pregnancy; SARS-CoV-2.